A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma

Journal of Urology

Volumn 156, Issue 2, 1996, Pages 372-376

  Lundholm, Carl ^a   Norlén, Bo Johan ^a   Ekman, Peter ^a   Jahnson, Staffan ^a   Lagerkvist, Mikael ^a   Lindeborg, Torsten ^a   Olsson, Jan Olov ^a   Tveter, Kjell ^a   Wijkström, Hans ^a   Westberg, Ronny ^a   Malmström, Per Uno ^a  

^a NONE

Author keywords

Bladder neoplasms; instillation; Drug; administration; Intravesical; mitomycin C; BCG vaccine

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BCG VACCINE; IMMUNOLOGICAL ADJUVANT; MITOMYCIN;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TIME; TUMOR RECURRENCE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; BCG VACCINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0030213699     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65853-1     Document Type: Article

References (10)

1. Utz, D. C., Hanash, K. A. and Farrow, G. M.: The plight of the patient with carcinoma in situ of the bladder. J. Urol., 103: 160, 1970.
2. Herr, H. W.: Intravesical therapy. A critical overview. Urol. Clin. N. Amer., 14: 399, 1987.
3. Lum, B. L. and Torti, F. M.: Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. J. Natl. Cancer Inst., 83: 682, 1991.
4. Rintala, E., Jauhiainen, K., Alfthan, O., Hansson, E., Juusela, H., Kanerva, K., Korhonen, H., Permi, J., Sotarauta, M., Vaalasti, T., Viitanen, J. and Usenius, R.: Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guérin) in superficial bladder cancer. Eur. Urol., 20: 19, 1991.
5. Hudson, M. A. and Herr, H. W.: Carcinoma in situ of the bladder. J. Urol., 153: 564, 1995.
6. Norming, U., Nyman, C. R. and Tribukait, B.: Comparative histopathology and deoxyribonucleic acid flow cytometry of random mucosal biopsies in untreated bladder carcinoma. J. Urol., 145: 1164, 1991.
7. Vegt, P. D. J., Witjes, J. A., Witjes, W. P. J., Doesburg, W. H., Debruyne, F. M. J. and van der Meijden, A. P. M.: A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder. J. Urol., part 2, 153: 929, 1995.
8. Lamm, D. L., Crawford, E. D., Blumenstein, B., Crissman, J., deVere White, R., Wolf, M., Lowe, B., Sarosdy, M., Schellhammer, P., Sagalowsky, A., Smith, J., Grossman, H. B., Flanigan, R., Moon, T., Brendler, C. and Coltman, C.: SWOG 8795: a randomized comparison of bacillus Calmette-Guérin and mitomycin C prophylaxis in stage Ta and T1 transitional cell carcinoma of the bladder. J. Urol., part 2, 149: 282A, abstract 275, 1993.
9. Krege, S., Otto, T., Rübben, H., Meyer, R., Giani, G. and participating clinics: Final report on a randomized multi-centre trial on adjuvant therapy in superficial bladder cancer: TUR only vs TUR + mitomycin vs TUR + bacillus Calmette Guerin. J. Urol., part 2, 155: 494A, abstract 734, 1996.
10. Nadler, R. B., Catalona, W. J., Hudson, M. A. and Ratliff, T. L.: Durability of the tumor-free response for intravesical bacillus Calmette-Guerin therapy. J. Urol., 152: 367, 1994.